Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulation 2015.

ROSSARI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+4.2%1-day move

₹426.90

prior close

₹428.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+3.5+3.6+2.2+1.7+4.2+6.1+5.4+6.6+5.2+12.7+10.1+15.0+19.2+24.9

Up moveDown movePending

AI summary

Rossari Biotech's material subsidiary Unitop Chemicals Private Limited has approved the sale of its office premises located at Saki Naka, Mumbai for approximately Rs. 10 crores. The transaction is expected to be completed by the end of Q2 FY27. The company has clarified that no business operations are conducted from these premises, so the sale will not impact the company's or subsidiary's business operations. The sale also does not constitute the sale of an undertaking under Section 180(1)(a) of the Companies Act, 2013.

Likely market impact

Minimal impact expected as this involves idle real estate with no operational disruption. The Rs. 10 crore deal size is relatively small relative to the company's scale.